Division of Endocrinology, Diabetes and Metabolism, Department of Medicine, Johns Hopkins University, Baltimore, MD.
Division of Vascular Surgery and Endovascular Therapy, Department of Surgery, Johns Hopkins University, Baltimore, MD.
Diabetes Care. 2018 Jul;41(7):1478-1485. doi: 10.2337/dc17-1683. Epub 2018 Apr 16.
This study evaluated the association between hemoglobin A (A1C) and wound outcomes in patients with diabetic foot ulcers (DFUs).
We conducted a retrospective analysis of an ongoing prospective, clinic-based study of patients with DFUs treated at an academic institution during a 4.7-year period. Data from 270 participants and 584 wounds were included in the analysis. Cox proportional hazards regression was used to assess the incidence of wound healing at any follow-up time in relation to categories of baseline A1C and the incidence of long-term (≥90 days) wound healing in relation to tertiles of nadir A1C change and mean A1C change from baseline, adjusted for potential confounders.
Baseline A1C was not associated with wound healing in univariate or fully adjusted models. Compared with a nadir A1C change from baseline of -0.29 to 0.0 (tertile 2), a nadir A1C change of 0.09 to 2.4 (tertile 3) was positively associated with long-term wound healing in the subset of participants with baseline A1C <7.5% (hazard ratio [HR] 2.07; 95% CI 1.08-4.00), but no association with wound healing was seen with the mean A1C change from baseline in this group. Neither nadir A1C change nor mean A1C change were associated with long-term wound healing in participants with baseline A1C ≥7.5%.
There does not appear to be a clinically meaningful association between baseline or prospective A1C and wound healing in patients with DFUs. The paradoxical finding of accelerated wound healing and increase in A1C in participants with better baseline glycemic control requires confirmation in further studies.
本研究评估了糖化血红蛋白(A1C)与糖尿病足溃疡(DFU)患者的伤口结局之间的关系。
我们对一家学术机构在 4.7 年期间治疗的 DFU 患者的一项正在进行的前瞻性临床研究进行了回顾性分析。共纳入了 270 名患者和 584 处伤口的数据。使用 Cox 比例风险回归来评估在任何随访时间点,与基线 A1C 类别相关的伤口愈合发生率,以及与最低 A1C 变化和从基线开始的 A1C 变化的平均值的三分位数相关的长期(≥90 天)伤口愈合发生率,调整了潜在的混杂因素。
基线 A1C 与单变量或完全调整模型中的伤口愈合无关。与基线 A1C 最低变化从 0.29 到 0.0(三分位 2)相比,基线 A1C<7.5%的患者中,最低 A1C 从基线的变化为 0.09 至 2.4(三分位 3)与长期伤口愈合呈正相关(风险比 [HR] 2.07;95%可信区间 1.08-4.00),但在该组中,从基线开始的平均 A1C 变化与伤口愈合无关。在基线 A1C≥7.5%的患者中,最低 A1C 变化和从基线开始的平均 A1C 变化均与长期伤口愈合无关。
DFU 患者的基线或前瞻性 A1C 与伤口愈合之间似乎没有临床意义上的关联。在血糖控制较好的患者中,出现愈合加速和 A1C 升高的矛盾发现需要进一步研究证实。